⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RIGL News
Rigel Pharmaceuticals Inc. (New)
Rigel to Present at the Jefferies Global Healthcare Conference
prnewswire.com
RIGL
Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress
prnewswire.com
RIGL
Form 8-K
sec.gov
RIGL
Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference
prnewswire.com
RIGL
Form 8-K
sec.gov
RIGL
Form 8-K
sec.gov
ARVN
RIGL
PFE
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ARVN
RIGL
PFE
Rigel Enters Exclusive Global Licensing Agreement for VEPPANU™ (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer
prnewswire.com
RIGL
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
globenewswire.com
ARVN
PFE
RIGL
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil
globenewswire.com
RIGL